- Home
- IPEX vs RCEL Comparison
IPEX vs RCEL Comparison
Compare IPEX & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPEX | RCEL |
|---|---|---|
| Founded | 2024 | N/A |
| Country | United States | United States |
| Employees | N/A | 226 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.4M | 132.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IPEX | RCEL |
|---|---|---|
| Price | $10.36 | $5.02 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.17 |
| AVG Volume (30 Days) | 20.4K | ★ 231.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.69 |
| Revenue Next Year | N/A | $49.58 |
| P/E Ratio | $41.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.25 | $3.22 |
| 52 Week High | $10.39 | $10.28 |
Technical Indicators
Market Signals| Indicator | IPEX | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 64.31 |
| Support Level | N/A | $4.92 |
| Resistance Level | $10.35 | $5.88 |
| Average True Range (ATR) | 0.04 | 0.40 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 44.44 | 62.92 |
Price Performance
Historical ComparisonAbout IPEX Inflection Point Acquisition Corp. V Class A Ordinary Shares
Inflection Point Acquisition Corp V is a blank check company.
About RCEL Avita Medical Inc.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.